<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lung transplantation is becoming an acceptable mode of therapy worldwide for the end-stage <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">lung disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We present our initial experience with the first 10 consecutive lung transplant patients at Hadassah University Hospital </plain></SENT>
<SENT sid="2" pm="."><plain>There were 5 males and 5 females with an age range 27 to 59 years </plain></SENT>
<SENT sid="3" pm="."><plain>Eight patients underwent single lung transplantation, one patient had double lung transplantation and one had heart-lung transplantation </plain></SENT>
<SENT sid="4" pm="."><plain>Indications were: <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo> in 4, <z:hpo ids='HP_0002097'>emphysema</z:hpo> in 4, cystic <z:mp ids='MP_0003045'>fibrosis</z:mp> in 1, and cystic <z:hpo ids='HP_0002110'>bronchiectasis</z:hpo> in 1 </plain></SENT>
<SENT sid="5" pm="."><plain>Two patients had primary graft failure (1 <z:hpo ids='HP_0011420'>death</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>Nine patients had a serious <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> after transplantation (1 <z:hpo ids='HP_0011420'>death</z:hpo>) </plain></SENT>
<SENT sid="7" pm="."><plain>Four patients developed airway complications including dehiscence of bronchial anastomosis (1 <z:hpo ids='HP_0011420'>death</z:hpo>), bronchial stenosis requiring placement of a stent in 2 patients, and <z:hpo ids='HP_0002107'>pneumothorax</z:hpo> in 1 patient </plain></SENT>
<SENT sid="8" pm="."><plain>One patient required tracheostomy </plain></SENT>
<SENT sid="9" pm="."><plain>One patient died of massive <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> secondary to pulmonary <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and embolization </plain></SENT>
<SENT sid="10" pm="."><plain>Six patients are intermediate-term survivors, with a follow-up period of 4-24 months </plain></SENT>
<SENT sid="11" pm="."><plain>Four of them had at least one episode of rejection each </plain></SENT>
<SENT sid="12" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> survivors pulmonary functions and quality of life improved and they do not need supplemental oxygen </plain></SENT>
<SENT sid="13" pm="."><plain>We conclude that lung transplantation is a viable option for end-stage <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">lung disease</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>Better selection of patients and perhaps improved immunosuppression agents will further improve outcome in lung transplantation </plain></SENT>
<SENT sid="15" pm="."><plain>Shortage of donor supply is currently the limiting factor in successful lung transplantation in Israel </plain></SENT>
</text></document>